PERIPROSTHETIC JOINT INFECTION (PJI)

Clinical trials for PERIPROSTHETIC JOINT INFECTION (PJI) explained in plain language.

Never miss a new study

Get alerted when new PERIPROSTHETIC JOINT INFECTION (PJI) trials appear

Sign up with your email to follow new studies for PERIPROSTHETIC JOINT INFECTION (PJI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New injection fights dangerous joint infections after knee replacement

Disease control Recruiting now

This early-stage study is testing whether a new drug called TNP-2092, injected directly into the joint, can help treat serious infections around artificial knee joints. The study will involve 33 people who have developed infections after knee replacement surgery, either recently …

Matched conditions: PERIPROSTHETIC JOINT INFECTION (PJI)

Phase: PHASE1, PHASE2 • Sponsor: TenNor Therapeutics Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

PERIPROSTHETIC JOINT INFECTION (PJI)

Get alerted when new PERIPROSTHETIC JOINT INFECTION (PJI) trials appear

New injection fights dangerous joint infections after knee replacement